Journey Medical Corp (DERM)
3.50
-0.12
(-3.31%)
USD |
NASDAQ |
May 01, 12:38
Journey Medical Cash from Operations (Quarterly): -16.52M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.52M |
| September 30, 2023 | 18.75M |
| June 30, 2023 | 3.969M |
| March 31, 2023 | -0.956M |
| December 31, 2022 | -3.836M |
| September 30, 2022 | -7.282M |
| Date | Value |
|---|---|
| June 30, 2022 | -3.30M |
| March 31, 2022 | 0.884M |
| December 31, 2021 | -3.206M |
| September 30, 2021 | 7.102M |
| June 30, 2021 | -7.438M |
| March 31, 2021 | 1.361M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.52M
Minimum
Dec 2023
18.75M
Maximum
Sep 2023
-0.8729M
Average
-2.081M
Median
Cash from Operations (Quarterly) Benchmarks
| Fortress Biotech Inc | -34.94M |
| Puma Biotechnology Inc | 10.46M |
| GT Biopharma Inc | -2.047M |
| FibroGen Inc | -18.32M |
| Outlook Therapeutics Inc | -13.03M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 19.21M |
| Free Cash Flow | 0.24M |
| Free Cash Flow Per Share (Quarterly) | -0.8549 |
| Free Cash Flow to Equity (Quarterly) | -31.14M |
| Free Cash Flow to Firm (Quarterly) | -16.52M |
| Free Cash Flow Yield | 0.36% |